Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

View Full Size 

Download

• Full Size JPEG, 1179x753, 173.2 KB
• Small JPEG, 480x307, 81.2 KB
• Preview JPEG, 144x92, 36.9 KB
• Thumbnail JPEG, 110x70, 32.7 KB